Watch RTGN. Know when insiders buy.
One email the day a filing lands. Free.
RTGN
RetinalGenix Technologies Inc.
3.99
+0.00 +0.00%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $75.2MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$2.1MNET CASH —52W 3.20 – 4.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | — | −$307K | — | -0.02 | −$137K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | — | −$590K | — | -0.03 | −$109K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | — | −$623K | — | -0.03 | −$128K | — | — | Apr 15 |
| Q3 2025 · Sep 30 | — | — | — | — | −$569K | — | -0.03 | −$104K | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | — | −$649K | — | -0.03 | −$139K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | — | −$587K | — | -0.03 | −$187K | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | — | — | — | — | −$867K | — | -0.05 | −$186K | — | — | Apr 15 |
| Q3 2024 · Sep 30 | — | — | — | — | −$644K | — | -0.04 | −$247K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | — | −$664K | — | -0.04 | −$145K | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | — | −$2.1M | — | -0.12 | −$164K | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | — | −$542K | — | -0.03 | −$290K | — | — | Mar 31 |
| Q3 2023 · Sep 30 | — | — | — | — | −$686K | — | -0.04 | $40K | — | — | Nov 18 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | −$2.4M | — | -0.13 | −$558K | — | — | — | — |
| FY2024 · to Dec 31 | — | — | — | −$4.3M | — | -0.24 | −$742K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | — | −$2.1M | — | -0.12 | −$452K | — | — | — | — |
| FY2022 · to Dec 31 | — | — | — | −$3.9M | — | -0.25 | −$199K | — | — | — | — |
| FY2021 · to Dec 31 | — | — | — | −$2.2M | — | -0.05 | −$1.2M | — | — | — | — |
| FY2020 · to Dec 31 | — | — | — | −$2.1M | — | -0.05 | −$1.4M | — | — | — | — |
Every number comes from RetinalGenix Technologies Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.